Research :: Taking animals out of laboratory research
Pioneering work to reduce the use of animals in scientific research — and ultimately remove them from laboratories altogether — has received a major boost at The University of Nottingham.
Pioneering work to reduce the use of animals in scientific research — and ultimately remove them from laboratories altogether — has received a major boost at The University of Nottingham.
It may not seem so at the time, but women who suffer through morning sickness during their pregnancies actually may be fortunate. Those women may have a 30 percent lower risk of developing breast cancer later in life than mothers-to-be who experience nine nausea-free months, a new study by epidemiologists at the University at Buffalo suggests.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Consultation seeks to stimulate debate on New Deal for Carers. Details of a huge national debate on how to improve the future of the nation’s six million carers were released today by Care Services Minister, Ivan Lewis.
A protein long thought to be one of the body?s supporting players has quietly been taking a lead role in healthy eyesight, a discovery that could rapidly lead to treatments for babies born before their eyes are finished growing, University of Florida and Harvard Medical School researchers have found.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.
Australian health practitioners now have new guidelines to help them discuss end-of-life issues with palliative care patients and their families.
The targeted use of an anti-estrogen drug could prolong the life of some ovarian cancer patients by up to three years, and delay the use of chemotherapy in others, revealed by researchers at the University of Edinburgh.
Prominent Medicare health plans strengthen consumer protections and voluntarily pledge to temporarily suspend non-group PFFS marketing. Statement of AHIP President and CEO Karen Ignagni on landmark industry pledge:
Rare, previously undetectable drug-resistant forms of HIV have been identified by Yale School of Medicine researcher Michael Kozal, M.D., using an innovative genome sequencing technology that quickly detects rare viral mutations.